Factors Associated with the Presence of Nonalcoholic Steatohepatitis in Patients with Chronic Hepatitis C

Solis-Herruzo, José A.; Pérez-Carreras, Mercedes; Rivas, Eloy; Fernández-Vázquez, Inmaculada; Garfia, Cristina; Bernardos, Esther; Castellano, Gregorio; Colina, Francisco
May 2005
American Journal of Gastroenterology;May2005, Vol. 100 Issue 5, p1091
Academic Journal
OBJECTIVES: The aim of this study was to identify factors associated with the presence of nonalcoholic steatohepatitis (NASH) in patients with chronic hepatitis C (CHC).METHODS: We studied 98 patients with CHC[47 with NASH (group HCV/NASH), 51 without NASH (group HCV)] and 85 with NASH not infected with hepatitis C virus (HCV) (group NASH). We determined factors associated with the presence of NASH in patients with hepatitis C.RESULTS: Group HCV/NASH patients resembled those with NASH. Body mass index (BMI) was higher in group HCV/NASH than in group HCV, but was similar to group NASH. Most HCV/NASH patients had risk factors for NASH. In patients infected with HCV, NASH and NASH-related lesions were independently associated with BMI, while steatosis score was associated with HCV genotype 3 and BMI. Fibrosis stage was independently associated with steatosis, necroinflammatory activity index, and NASH lesions.CONCLUSION: While HCV genotype 3 infection and BMI are associated with the presence of steatosis in CHC, BMI is the only factor independently associated with the presence of NASH in these patients. We suggest that overweight-related factors might induce NASH in CHC patients.(Am J Gastroenterol 2005;100:1091–1098)


Related Articles

  • Hepatocellular fat accumulation and low serum cholesterol in patients infected with HCV-3a. Hofer, Harald; Bankl, Hans C.; Wrba, Friedrich; Steindl-Munda, Petra; Peck-Radosavljevic, Markus; Österreicher, Christoph; Mueller, Christian; Gangl, Alfred; Ferenci, Peter // American Journal of Gastroenterology;Nov2002, Vol. 97 Issue 11, p2880 

    OBJECTIVES:The aim of this study was to prospectively investigate the prevalence of hepatic steatosis in chronic hepatitis C patients with respect to viral genotype, hepatic iron concentration, total body iron, body mass index, and serum lipid parameters. Furthermore, the effect of hepatitis C...

  • Hepatitis C and Menopause. Speroff, Leon // OB/GYN Clinical Alert;Jul2007, Vol. 24 Issue 3, p23 

    Codes and colleagues from France followed a cohort of 251 women with chronic hepatitis C, and report data associating the severity of fibrosis established by liver biopsies with menopause and hormone therapy. There were 4 principal factors influencing the severity of fibrosis: duration of...

  • Insulin resistance and steatosis in hepatitis C virus infection. Zekry, A.; McHutchison, J. G.; Diehl, A. M. // Gut;Jul2005, Vol. 54 Issue 7, p903 

    The article discusses insulin resistance (IR) and steatosis in hepatitis C virus (HCV) infection. Steatosis in patients with genotype 1 infection is increasingly recognized as a component of the metabolic syndrome, a condition invariably associated with IR. In support, host factors such as age,...

  • NRTIs associated with hepatic steatosis in HIV/HCV co-infection.  // Reactions Weekly;7/29/2006, Issue 1112, p3 

    This article discusses research being done on the use of nucleoside reverse transcriptase inhibitors (NRTIs) in patients with HIV and hepatitis C virus (HCV) co-infection. It references a study by B. H. McGovern et al published in the August 1, 2006 issue of the journal "Clinical Infectious...

  • Serum leptin levels correlate with hepatic steatosis in chronic hepatitis C. Romero-Gómez, Manuel; Castellano-Megias, Victor M.; Grande, Lourdes; Irles, José A.; Cruz, Marina; Nogales, Marí Carmen; Alcón, Juan Carlos; Robles, Antonio // American Journal of Gastroenterology;May2003, Vol. 98 Issue 5, p1135 

    : ObjectivesHepatic steatosis (HS) has been related to obesity and fibrosis in chronic hepatitis C (CHC). The aim of this study was to determine the role of leptin system in HS development.: MethodsPatients (n = 131) with biopsy-proven CHC, positive HCV RNA, and raised ALT were enrolled. Body...

  • Prevalence and impact of hepatic steatosis on the response to antiviral therapy in Saudi patients with genotypes 1 and 4 chronic hepatitis C. AlQaraawi, Abdallah; Sanai, Faisal; Al-Husseini, Hussa; Albenmousa, Ali; AlSheikh, Abdulmalik; Ahmed, Lubna; Hersi, Ahmad; Al-Otaibi, Molfi; Syed, Mohammed; Ali, Safiyya; Al-hamoudi, Waleed; Alswat, Khalid; Abdo, Ayman; AlQaraawi, Abdallah M; Sanai, Faisal M; Ahmed, Lubna Rizwan; Al-Otaibi, Molfi M; Ali, Safiyya M; Alswat, Khalid A; Abdo, Ayman A // Digestive Diseases & Sciences;Apr2011, Vol. 56 Issue 4, p1222 

    Background: Hepatic steatosis in hepatitis C virus (HCV)-infected patients has been shown to enhance the progression of liver fibrosis and decrease the response to antiviral therapy.Aims: We aimed to determine the role of HCV genotype 4 (HCV-G4) in the prevalence of...

  • Association of steatosis with histopathological grading and staging of liver biopsies in hepatitis C patients. Syed, Shuja Izhar; Sadiq, Saleem // Pakistan Journal of Medical Sciences;Apr2011, Vol. 27 Issue 3, p638 

    Objective: To find out the association of steatosis with histopathological grading and staging of liver biopsies in hepatitis C patients. Methodology: This was a prospective study based on liver biopsies of hepatitis C patients. H and E stained slides were examined to determine the histological...

  • Effect of PNPLA3 rs738409 variant (I148 M) on hepatic steatosis, necroinflammation, and fibrosis in Japanese patients with chronic hepatitis C. Yasui, Kohichiroh; Kawaguchi, Takahisa; Shima, Toshihide; Mitsuyoshi, Hironori; Seki, Kojiro; Sendo, Rei; Mizuno, Masayuki; Itoh, Yoshito; Matsuda, Fumihiko; Okanoue, Takeshi // Journal of Gastroenterology;Aug2015, Vol. 50 Issue 8, p887 

    Background: Host genetic factors have been suspected to influence histological liver damage in chronic liver disease. The nonsynonymous single-nucleotide polymorphism rs738409 C > G in the patatin-like phospholipase domain-containing 3 gene ( PNPLA3, also known as adiponutrin), encoding the I148...

  • Dysplasia Associated Lesion or Mass (DALM) in a Hepatitis C Patient: a case report. Alleemudder, Adam; Kumar, Ravi // Internet Journal of Gastroenterology;2010, Vol. 9 Issue 2, p4 

    Dysplasia Associated Lesion or Mass(DALM) are rare but pre-malignant lesions found in Ulcerative Colitis. Their macroscopic appearance maybe mistaken for colorectal cancer. There are several well known malignant associations with Hepatitis C infection but not colorectal cancer. We report an...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics